Letters, Testimony & Comments

February 10, 2005
Testimony to oppose Hawaii Senate Bill 1036 which "provides strict liability for injuries caused by biotech products from plant sources" (February 10, 2005).
February 10, 2005
Testimony to oppose Senate Bills 1425 and 1692 which relate the regulation of bioprospecting (February 10, 2005).
February 10, 2005
Testimony to oppose Senate Bills 644, 645, 647, 649, 1037, 1847 which propose to restrict or ban or otherwise regulate various aspects of agricultural biotechnology (February 10, 2005).
February 9, 2005
to place liability on manufacturers for "claims and damages resulting from the use, according to the label and directions for use, of genetically engineered seeds and plant parts." (February 9, 2005).
January 31, 2005
Supporting House Bill 1268, which would preserve therapeutic cloning research in the state
January 31, 2005
Supporting House Bill 1268, which would preserve therapeutic cloning research in the state (January 31, 2005).
January 9, 2005
BIO's comments on the Proposed Bulletin for Good Guidance Practices released by the Office of Management and Budget (OMB).
January 9, 2005
BIO's comments on the Centers for Medicare and Medicaid Servicesí final rule regarding revisions to the hospital outpatient prospective payment system (OPPS).
January 5, 2005
Docket No. 2004D-0440, Federal Register: October 4th, 2004 (Volume 69, Pages 59239-59240).
December 23, 2004
As posted on CMS's Web site on December 3, 2004
November 20, 2004
Janna Tom, Assistant Director, Office of Technology Transfer, University of California; Vice President for Public Policy, Association of University Technology Managers (AUTM), USA Mission: -Research or Knowledge Generation -Education/Training...
November 16, 2004
To the Members of the U.N. General Assembly: The Biotechnology Industry Organization (BIO) represents more than 1,000 biotechnology companies, academic institutions, state biotechnology centers and related organizations in all 50 U.S. states and...